The company bears significant ethical and scientific responsibilities due to its direct influence on public health and community safety.
Central to this responsibility is the development of effective and safe medicines, which must be grounded in rigorous scientific research and strict compliance with international safety and quality standards. Transparency in clinical trials is essential, including the publication of both positive and negative results, to uphold the integrity of scientific knowledge and protect patients from misinformation.
Equally important is the obligation to ensure equitable access to essential medicines, particularly in developing countries and during health crises, where affordability becomes a critical concern. Ethical lapses such as aggressive, non-evidence-based drug promotion undermine professional integrity and public trust.
In this regard, continuous collaboration with international regulatory bodies—such as the World Health Organization and national drug authorities—is vital for maintaining up-to-date standards that reflect current medical advances.
Ultimately, integrating ethical conduct with strategic decision-making is not only a moral duty but also a cornerstone for sustaining public confidence in the healthcare system and contributing to global health resilience.